Calalagan, Zamra B.
HRN: 24-69-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2024
CEFTRIAXONE 1G (VIAL)
03/19/2024
03/26/2024
IV
1g
Every 12 Hours
HNP, For Laminectomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes